Moderna shares were up 4.9% in premarket trading after the Food and Drug Administration approved its newest Covid-19 vaccine over the weekend. Shares were trading around $27.85. The stock is down 36% ...

"To enroll our first patients just over two months after announcing our $110 million Series B round demonstrates the Curevo ...

Rep. Marjorie Taylor Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine, describing the move as "Not MAHA at all!!!' in a post on X ...

Public health experts say Robert F. Kennedy Jr is exactly who they thought he was. The Health and Human Services (HHS) secretary — who is also the nation’s most well-known vaccine skeptic — ...

The US Department of Health and Human Services is no longer recommending COVID vaccines for pregnant women and children. Big ...

WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming ...

In May, prominent members of the Make America Great Again movement, including Nicole Shanahan, Kennedy's former presidential running mate, and media personality Laura Loomer, spoke out against Kennedy ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

US Food and Drug Administration (FDA) has approved mNEXSPIKE (mRNA-1283), a new vaccine against Covid-19, for use in all adults 65 and older, as well as individuals aged 12-64 years with at least one ...

Investor sentiment toward Moderna Inc. turned sour during the weekend, despite obtaining FDA authorization for its newest ...

CHENNAI: The US Food and Drug Administration (FDA) on Saturday officially approved Moderna’s next-generation COVID-19 vaccine for use in key high-risk populatio ...

The FDA’s approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...